Publikation:

NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network

Lade...
Vorschaubild

Dateien

Mammarella_2-81pdn195e1zt2.pdf
Mammarella_2-81pdn195e1zt2.pdfGröße: 1.56 MBDownloads: 113

Datum

2021

Autor:innen

Mammarella, Eleonora
Zampieri, Carlotta
Panatta, Emanuele
Melino, Gerry

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Link zur Lizenz

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Biology Direct. BioMed Central. 2021, 16, 11. eISSN 1745-6150. Available under: doi: 10.1186/s13062-021-00296-5

Zusammenfassung

Most inactivating mutations in TP53 gene generates neomorphic forms of p53 proteins that experimental evidence and clinical observations suggest to exert gain-of-function effects. While massive effort has been deployed in the dissection of wild type p53 transcriptional programme, p53 mutant pro-tumorigenic gene network is still largely elusive. To help dissecting the molecular basis of p53 mutant GOF, we performed an analysis of a fully annotated genomic and transcriptomic human pancreatic adenocarcinoma to select candidate players of p53 mutant network on the basis their differential expression between p53 mutant and p53 wild-type cohorts and their prognostic value. We identified NUAK2 and RCan2 whose p53 mutant GOF-dependent regulation was further validated in pancreatic cancer cellular model. Our data demonstrated that p53R270H can physically bind RCan2 gene locus in regulatory regions corresponding to the chromatin permissive areas where known binding partners of p53 mutant, such as p63 and Srebp, bind. Overall, starting from clinically relevant data and progressing into experimental validation, our work suggests NUAK2 and RCan2 as novel candidate players of the p53 mutant pro-tumorigenic network whose prognostic and therapeutic interest might attract future studies.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Tumour suppression, Metastasis, Tumour progression, Cancer prognosis

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690MAMMARELLA, Eleonora, Carlotta ZAMPIERI, Emanuele PANATTA, Gerry MELINO, Ivano AMELIO, 2021. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network. In: Biology Direct. BioMed Central. 2021, 16, 11. eISSN 1745-6150. Available under: doi: 10.1186/s13062-021-00296-5
BibTex
@article{Mammarella2021NUAK2-56524,
  year={2021},
  doi={10.1186/s13062-021-00296-5},
  title={NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network},
  volume={16},
  journal={Biology Direct},
  author={Mammarella, Eleonora and Zampieri, Carlotta and Panatta, Emanuele and Melino, Gerry and Amelio, Ivano},
  note={Article Number: 11}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/56524">
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-11T07:56:09Z</dcterms:available>
    <dc:creator>Mammarella, Eleonora</dc:creator>
    <dc:creator>Zampieri, Carlotta</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/56524"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56524/3/Mammarella_2-81pdn195e1zt2.pdf"/>
    <dc:contributor>Mammarella, Eleonora</dc:contributor>
    <dc:contributor>Zampieri, Carlotta</dc:contributor>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:language>eng</dc:language>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dcterms:abstract xml:lang="eng">Most inactivating mutations in TP53 gene generates neomorphic forms of p53 proteins that experimental evidence and clinical observations suggest to exert gain-of-function effects. While massive effort has been deployed in the dissection of wild type p53 transcriptional programme, p53 mutant pro-tumorigenic gene network is still largely elusive. To help dissecting the molecular basis of p53 mutant GOF, we performed an analysis of a fully annotated genomic and transcriptomic human pancreatic adenocarcinoma to select candidate players of p53 mutant network on the basis their differential expression between p53 mutant and p53 wild-type cohorts and their prognostic value. We identified NUAK2 and RCan2 whose p53 mutant GOF-dependent regulation was further validated in pancreatic cancer cellular model. Our data demonstrated that p53R270H can physically bind RCan2 gene locus in regulatory regions corresponding to the chromatin permissive areas where known binding partners of p53 mutant, such as p63 and Srebp, bind. Overall, starting from clinically relevant data and progressing into experimental validation, our work suggests NUAK2 and RCan2 as novel candidate players of the p53 mutant pro-tumorigenic network whose prognostic and therapeutic interest might attract future studies.</dcterms:abstract>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56524/3/Mammarella_2-81pdn195e1zt2.pdf"/>
    <dcterms:issued>2021</dcterms:issued>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-11T07:56:09Z</dc:date>
    <dc:contributor>Panatta, Emanuele</dc:contributor>
    <dcterms:title>NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network</dcterms:title>
    <dc:contributor>Melino, Gerry</dc:contributor>
    <dc:creator>Melino, Gerry</dc:creator>
    <dc:creator>Panatta, Emanuele</dc:creator>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Amelio, Ivano</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja
Diese Publikation teilen